Dose Ranging Study of Metronidazole Vaginal Gel in the Treatment of Bacterial Vaginosis

PHASE2CompletedINTERVENTIONAL
Enrollment

255

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
Vaginosis, BacterialVaginal Infection
Interventions
DRUG

GW05

vaginal gel once daily regimen A

DRUG

GW05

vaginal gel once daily regimen B

DRUG

GW05

vaginal gel once daily regimen C

DRUG

Metronidazole

vaginal gel 0.75% once daily for 5 days

Trial Locations (20)

19102

Drexel University College of Medicine, Philadelphia

23502

Tidewater Physicians for Women, Norfolk

30075

Atlanta North Gynecology, Roswell

33143

Miami Research Associates, Miami

33161

Segal Institiute for Clinical Research, North Miami

33324

All Women's Healthcare of West Broward, Plantation

38120

Adams Patterson OBGYN, Memphis

38305

Jackson Clinic, Jackson

48604

Saginaw Valley Medical Research Group, Saginaw

49503

Grand Rapids Women's Health, Grand Rapids

61820

Women's Health Practice, Champaign

72401

NEA Women's Clinic, Jonesboro

77054

TMC Life Research, Houston

78705

Women's Partners in Health, Austin

80218

Downtown Women's Healthcare, Denver

85015

Women's Health Research, Phoenix

85032

Precision Trials, Phoenix

92123

Women's Health Center Inc, San Diego

01830

ActivMed Practices & Research, Haverhill

08536

Women's Health Research Center, Plainsboro

Sponsors
All Listed Sponsors
lead

Graceway Pharmaceuticals, LLC

INDUSTRY